Last week, two of the biggest and oldest companies in the burgeoning AI drug discovery space announced a surprise merger. In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Step into most college classrooms today and you will likely see a familiar scene: slides glowing at the front, a professor lecturing, students scribbling notes or staring at laptops. Despite decades ...
Last May, I gave a lecture at the Air War College, the Air Force’s senior service school for officers. I have taught at West Point and spoken at several other senior service schools. At the Air War ...
Before her career as a novelist, Toni Morrison was a teacher. The famed American author, best known for works such as Beloved and Song of Solomon, was born in Lorain, Ohio, in 1931. After attending ...
Each semester, the Connell School brings to Boston College an inspiring leader who speaks on an issue at the forefront of health care. Pinnacle lectures are open to all Boston College students, staff, ...
Wanna see a trick? Give us any topic and we can tie it back to the economy. At Planet Money, we explore the forces that shape our lives and bring you along for the ride. Don't just understand the ...
UC Berkeley researchers work every day to make discoveries that change the world. Whether advancing cures for Alzheimer’s, trailblazing the future of AI, or mapping the edges of the universe, our ...
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...